NCT07094945View on ClinicalTrials.gov

The Effect of Remimazolam on Postoperative Sleep Quality

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

August 15, 2025

Primary Completion Date

August 30, 2026

Study Completion Date

September 30, 2026

Conditions
Gynecological Day Surgery
Interventions
DRUG

Remimazolam

Remimazolam 0.3 mg/kg is slowly injected intravenously until loss of consciousness. Remimazolam 0.6-1.0 mg/kg·h is used for anesthesia maintenance.

DRUG

Propofol

Propofol 2 mg/kg is slowly injected intravenously until loss of consciousness. Remimazolam 4-12 mg/kg·h is used for anesthesia maintenance

All Listed Sponsors
lead

Tongji Hospital

OTHER